0HHJ logo

Arch Therapeutics LSE:0HHJ Stock Report

Last Price

US$0.80

Market Cap

US$14.8m

7D

0%

1Y

n/a

Updated

03 Feb, 2024

Data

Company Financials

0HHJ Stock Overview

Operates as a biotechnology company in the United States.

0HHJ fundamental analysis
Snowflake Score
Valuation0/6
Future Growth0/6
Past Performance0/6
Financial Health0/6
Dividends0/6

Arch Therapeutics, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Arch Therapeutics
Historical stock prices
Current Share PriceUS$0.80
52 Week HighUS$0.80
52 Week LowUS$0.80
Beta3.43
11 Month Change0%
3 Month Changen/a
1 Year Changen/a
33 Year Changen/a
5 Year Changen/a
Change since IPO-99.00%

Recent News & Updates

Recent updates

Shareholder Returns

0HHJGB Medical EquipmentGB Market
7D0%-1.5%0.4%
1Yn/a-4.8%7.6%

Return vs Industry: Insufficient data to determine how 0HHJ performed against the UK Medical Equipment industry.

Return vs Market: Insufficient data to determine how 0HHJ performed against the UK Market.

Price Volatility

Is 0HHJ's price volatile compared to industry and market?
0HHJ volatility
0HHJ Average Weekly Movementn/a
Medical Equipment Industry Average Movement5.8%
Market Average Movement4.7%
10% most volatile stocks in GB Market9.9%
10% least volatile stocks in GB Market2.5%

Stable Share Price: 0HHJ has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine 0HHJ's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
20068Terrence Norchiwww.archtherapeutics.com

Arch Therapeutics, Inc., together with its subsidiaries, operates as a biotechnology company in the United States. The company develops and markets products based on its AC5 self-assembling technology platform to stop bleeding and control leaking, as well as manages wounds during surgery, trauma, and interventional care or from disease. Its flagship products include AC5 advanced wound system and AC5 topical hemostat, which are intended for skin applications, such as management of complicated chronic wounds or acute surgical wounds.

Arch Therapeutics, Inc. Fundamentals Summary

How do Arch Therapeutics's earnings and revenue compare to its market cap?
0HHJ fundamental statistics
Market capUS$14.85m
Earnings (TTM)-US$6.41m
Revenue (TTM)US$37.77k

393.1x

P/S Ratio

-2.3x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
0HHJ income statement (TTM)
RevenueUS$37.77k
Cost of RevenueUS$55.01k
Gross Profit-US$17.23k
Other ExpensesUS$6.40m
Earnings-US$6.41m

Last Reported Earnings

Jun 30, 2023

Next Earnings Date

n/a

Earnings per share (EPS)-1.35
Gross Margin-45.63%
Net Profit Margin-16,980.91%
Debt/Equity Ratio-75.9%

How did 0HHJ perform over the long term?

See historical performance and comparison